The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...
An elderly Alzheimer's patient was denied coverage due to a botched assessment containing another patient's details, forcing ...
Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...
A SIMPLE blood test that could catch dementia before major symptoms start has begun trials in NHS clinics. More than 3,000 ...
Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...
Prolonged rapid eye movement sleep latency may be an early indicator of Alzheimer’s disease and related dementias, according ...
PEOPLE often think of Alzheimer’s when they think of dementia. It’s the most common type of dementia, accounting for 60-80 ...
COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
The research teams will build on recent breakthroughs in dementia blood tests, generating the evidence needed for them to be used in the NHS to improve diagnosis of dementia. Professor Fiona Carragher ...